Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01211418 · ClinicalTrials.gov registry record · NA
Integrative Meditation (IM) for Cocaine Addiction
A NA study of Cocaine Addiction, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 3
- Study locations
NCT01211418 is a NA study of Cocaine Addiction that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 66 participants, below the 74-participant average among 5 other Cocaine Addiction trials with a reported enrollment target (11% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT01211418, a NA study of Cocaine Addiction, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 3
- Study locations
Study Summary
Cocaine addiction continues to be a major problem in the U.S. with no FDA-approved pharmaceutical therapy. Finding effective treatment for cocaine addiction has long been a challenge to scientists and clinicians. Psychosocial interventions known as behavior therapies are the cornerstone of cocaine addiction treatment. However, there is an urgent need to further improve treatment outcomes, especially during early recovery and the protracted withdrawal phase of the treatment since many patients drop out or relapse during this phase. Our clinical experience and studies suggest that integrative Meditation (IM) helps reduce cravings and withdrawal symptoms and increases treatment retention. The benefit of IM is well supported by tension-reduction theory and attention-networks framework in addiction treatment. The proposed study will implement a therapy development study to add IM as a self-care component to the current outpatient treatment of cocaine addiction to improve treatment outcomes. The specific aims of the proposed study include: 1) to conduct a 12-week controlled trial with outpatient cocaine users to assess feasibility of recruiting and retaining cocaine addicts and to determine effect size of IM-augmented treatment in comparison with Nondirective Therapy (NT) control, with both groups receiving standard outpatient treatment as usual (TAU), thereby facilitating future larger scale therapy development study; and 2) to examine the changes in attention networks and negative mood as possible mediators of treatment outcomes between the two groups.
Conditions Studied
Interventions
- BEHAVIORAL Supportive Counseling
- BEHAVIORAL Integrative Meditation
Study Locations (3)
Maryland
- Alcohol and Drug Abuse Program (ADAP) - Baltimore
- Outpatient Addiction Treatment Service (OATS) - Baltimore
- University of Maryland Methadone Treatment Program - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2009-03 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01211418
The ClinicalTrials.gov registry entry for NCT01211418 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 74-participant average among 5 other Cocaine Addiction trials with a reported enrollment target (11% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cocaine Addiction appearing as the primary indexed condition, and to 2 interventions - of which Supportive Counseling is the first listed.
NCT01211418 reports 3 study locations spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01211418 about?
NCT01211418 is a clinical study titled "Integrative Meditation (IM) for Cocaine Addiction". Cocaine addiction continues to be a major problem in the U.S. with no FDA-approved pharmaceutical therapy. Finding effective treatment for cocaine addiction has long been a challenge to scientists and clinicians. Psychosocial interventions known as behavior therapies are the cornerstone of cocaine a...
What is the current status of trial NCT01211418?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2009-03. Estimated completion is 2012-03.
What conditions does trial NCT01211418 study?
This clinical trial studies the following conditions: Cocaine Addiction.
What interventions are being tested in trial NCT01211418?
The interventions under investigation include: Supportive Counseling (BEHAVIORAL), Integrative Meditation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01211418?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01211418 being conducted?
This trial has 3 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise as a Behavioral Treatment for Cocaine Dependence
COMPLETED · NA
-
A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction
COMPLETED · NA
-
Vigabatrin Ph 1 Cocaine Interaction Study
COMPLETED · Phase 1
-
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
COMPLETED · Phase 1
-
Vigabatrin for the Treatment of Cocaine Dependency
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.